ARTIS Ventures led the financing with participation from new and existing investors, raising over $39 million to date Funds will support ongoing commercial pilot program in Mexico City and preparations for U.S. launch timed for early 2026 A Media Snippet accompanying this announcement is available by clicking on this link. NEW YORK, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Conceivable Life Sciences (Conceivable), a biotech company revolutionizing the future of fertility care with the end-to-end automation of the ...